• Top Posts

In the Misleading the Public Department

This is interesting. Note; the article says almost the exact opposite of what the heading claims the article to be about.

Study finds no adverse effect of antipsychotics on blood sugar, cholesterol levels.

The study, if you read a little further, is not about the “adverse effect of antipsychotics on blood sugar, cholesterol levels”, it is rather about the monitoring by doctors of those adverse effects. That is to say there may be adverse effects, in fact, there are, doctors are just not monitoring for those adverse effects the way they would be if they were concerned about their patients’ health and well being.

Despite a warning from the Food and Drug Administration, blood sugar and cholesterol monitoring of patients using newer antipsychotic medications remains low, a new study published in the Archives of General Psychiatry has found.

With funding from Pfizer, researchers in Oregon State University, Emory University and other research institutions in Colorado and Missouri analyzed data from 109,000 Medicaid patients. They found that doctors had largely ignored the FDA warning, released in 2003, to screen patients using the “second generation” antipsychotic medications, which includes a broad range of drugs such as Pfizer’s Geodon (ziprasidone) and AstraZeneca’s Seroquel (quetiapine fumarate), for high blood sugar and cholesterol, which the drugs are known to increase, along with weight gain and the risk of diabetes

This story was published in Drug Store News which may help to explain the confusion a little bit. I suppose the author was expecting people to only read the headline, and skip the article.